CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 37 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | HEDRICK MARC H Chief Executive Officer | Purchase | +5,000 | $0.65 | $3K | 33,580 |
| 2022-06-02 | Clowes Howard Director | Purchase | +15,000 | $0.57 | $9K | 18,000 |
| 2022-05-17 | Petersen Greg Director | Purchase | +30,000 | $0.55 | $17K | 62,500 |
| 2022-04-26 | HEDRICK MARC H Chief Executive Officer | Purchase | +2,500 | $0.68 | $2K | 28,580 |
| 2022-04-26 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +3,000 | $0.67 | $2K | 12,230 |
| 2022-04-26 | HEDRICK MARC H Chief Executive Officer | Purchase | +5,000 | $0.69 | $3K | 26,080 |
| 2022-03-01 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +2,000 | $1.10 | $2K | 9,230 |
| 2021-11-11 | LaFrance Norman D. CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy shares of common stock) | +120,000 | 120,000 | ||
| 2021-11-02 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +1,000 | $1.86 | $2K | 7,230 |
| 2021-11-01 | LaFrance Norman D. CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy shares of common stock) | +120,000 | 120,000 | ||
| 2021-10-27 | Petersen Greg Director | Purchase | +12,500 | $1.72 | $22K | 32,500 |
| 2021-10-26 | HEDRICK MARC H Chief Executive Officer | Purchase | +2,500 | $1.66 | $4K | 21,080 |
| 2021-10-26 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +2,000 | $1.67 | $3K | 6,230 |
| 2021-09-13 | Lenk Robert P Director | Purchase | +7,000 | $1.86 | $13K | 10,000 |
| 2021-07-28 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +2,244 | $1.91 | $4K | 4,230 |
| 2021-07-27 | Sims Andrew John Hugh MacIntyre Chief Financial Officer | Purchase | +1,986 | $2.05 | $4K | 1,986 |
| 2021-06-11 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-06-11 | Hawkins Richard J Director | Grant or award · Stock Option (Right to Buy) | +6,336 | 6,336 | ||
| 2021-05-25 | HEDRICK MARC H Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,771 | 200,771 | ||
| 2021-05-25 | van Es-Johansson An Director | Grant or award · Stock Option (Right to Buy) | +6,336 | 6,336 |
Page 9 of 53 · 1,048 trades